Adaptive Biotechnologies Corp ADPT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/15/22 EDT
13.32quote price arrow up+0.65 (+5.13%)
Volume
503,166
Close
12.67UNCH (UNCH)
Volume
1,517,861
52 week range
5.96 - 40.00
Loading...
  • Open12.26
  • Day High12.79
  • Day Low12.21
  • Prev Close12.32
  • 52 Week High40.00
  • 52 Week High Date09/07/21
  • 52 Week Low5.96
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap1.81B
  • Shares Out142.87M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-54.85

KEY STATS

  • Open12.26
  • Day High12.79
  • Day Low12.21
  • Prev Close12.32
  • 52 Week High40.00
  • 52 Week High Date09/07/21
  • 52 Week Low5.96
  • 52 Week Low Date06/14/22
  • Market Cap1.81B
  • Shares Out142.87M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-54.85

RATIOS/PROFITABILITY

  • EPS (TTM)-1.64
  • P/E (TTM)-7.72
  • Fwd P/E (NTM)-7.96
  • EBITDA (TTM)-213.262M
  • ROE (TTM)-38.32%
  • Revenue (TTM)159.68M
  • Gross Margin (TTM)65.58%
  • Net Margin (TTM)-145.44%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptive Biotechnologies Corp

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain...
Chad Robins
Chairman of the Board, Chief Executive Officer, Co-Founder
Julie Rubinstein
President
Mark Adams Ph.D.
Chief Operating Officer
Tycho Peterson
Chief Financial Officer
Address
1165 Eastlake Ave E
Seattle, WA
98109
United States

Top Peers

SYMBOLLASTCHG%CHG
BBIO
BridgeBio Pharma Inc
11.56UNCHUNCH
PACB
Pacific Biosciences of California Inc
8.36UNCHUNCH
LGND
Ligand Pharmaceuticals Inc
107.31UNCHUNCH
PRTA
Prothena Corporation PLC
32.66UNCHUNCH
RVNC
Revance Therapeutics Inc
22.12UNCHUNCH